Acting FTC chairman says deal with China with carrots and sticks
Acting FTC Chair Maureen Ohlhausen says the U.S. has to point out the bad and recognize the good in antitrust issues with China.
Shire Rejects $46B AbbVie Offer
The proposal followed two other pitches from AbbVie, which wants to move its tax domicile to the U.K.
Shire Quickly Pulls Off Dermagraft
Irish pharmaceuticals company Shire said on Friday it had arranged to hand its Dermagraft skin substitute to Organogenesis and take a $650 million loss on the disposal, which unwinds a major part of an acquisition it made less than three years ago.
Market Up on Deals, Results
Markets edged higher as some stocks jumped on deal making, with key retailer results to be closely watched this week.
Shire Deal Just The Start
Shire's purchase of ViroPharma is a signal of deals and higher prices ahead, says Jason Kolbert, Sr. Research Analyst at the Maxim Group.
Elon Musk Says Only Two Things Could Make Him Leave Tesla
Tesla CEO Musk discusses succession plans and Twitter with shareholders.
Caesars Inches Closer to Huge Las Vegas Strip Move
The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.
Elon Musk Has Bad News About Tesla's Cybertruck
Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023